Physician profile
Brian J Bohner
NPI 1598855124
$75,158.27
in general payments reported to CMS, 2019-2025
52 companies · $22K in 2025
The $22K reported for 2025 was more than what 95% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,057 · 2020: $519 · 2021: $1,580 · 2022: $5,349 · 2023: $21K · 2024: $24K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Honoraria: $12K · Food and Beverage: $9,326 · Travel and Lodging: $5,464 · Consulting Fee: $1,090 · Education: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,965.00 |
| Honoraria | $12,475.00 |
| Food and Beverage | $9,326.27 |
| Travel and Lodging | $5,463.74 |
| Consulting Fee | $1,090.00 |
| Education | $332.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $40,835.65 | 2019-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $18,908.59 | 2023-2025 | Lumryz |
| Axsome Therapeutics, INC. | $3,194.87 | 2023-2025 | Sunosi, Auvelity |
| Glaxosmithkline, LLC. | $2,098.98 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,590.35 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Harmony Biosciences LLC | $1,382.73 | 2020-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $711.72 | 2019-2025 | Ofev, Stiolto Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $517.94 | 2020-2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $500.83 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $460.73 | 2019-2024 | Yupelri |
| Amgen INC. | $448.59 | 2021-2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $415.21 | 2019-2025 | |
| Genentech USA, INC. | $409.01 | 2019-2025 | Xolair |
| Grifols USA, LLC | $365.56 | 2019-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $338.11 | 2021-2025 | Acthar |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $326.02 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Genzyme Corporation | $315.44 | 2021-2025 | |
| Insmed, INC. | $290.87 | 2019-2025 | Arikayce |
| United Therapeutics Corporation | $217.98 | 2019-2025 | Tyvaso, Tyvaso |
| Merck Sharp & Dohme LLC | $208.94 | 2019-2025 | Belsomra, Keytruda, Zerbaxa |
| Philips North America LLC | $170.41 | 2019-2023 | |
| Electromed, INC. | $151.64 | 2019-2025 | Smartvest |
| Alexion Pharmaceuticals, INC. | $102.25 | 2019-2021 | |
| Shire North American Group INC | $87.53 | 2019 | |
| Baxter Healthcare | $80.96 | 2024-2025 | Hillrom - Volara System, Hillrom - Vest System Model 105 Home Care |
| Gilead Sciences, INC. | $78.80 | 2021-2022 | |
| 3b Medical, INC. | $75.11 | 2024-2025 | Luna |
| Vifor Pharma, INC. | $72.36 | 2024-2025 | Zemaira |
| Pfizer INC. | $70.44 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $70.28 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $61.89 | 2019 | |
| Itamar Medical INC | $52.85 | 2021 | |
| Ani Pharmaceuticals, INC. | $51.57 | 2022 | |
| Fisher & Paykel Healthcare INC | $47.93 | 2019-2020 | |
| Idorsia Pharmaceuticals US INC | $43.21 | 2022-2023 | Quviviq |
| Tactile Systems Technology INC | $42.88 | 2024 | Flexitouch Plus, Entre Plus |
| Inogen, INC. | $38.86 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Mallinckrodt Enterprises LLC | $32.17 | 2019 | |
| Resmed Corp | $29.70 | 2019 | |
| Abbvie INC. | $25.88 | 2024 | |
| Shionogi INC | $25.73 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $24.89 | 2019-2022 | |
| Viatris Specialty LLC | $24.23 | 2025 | Yupelri |
| Vapotherm INC | $24.14 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.76 | 2019 | |
| Nabriva Therapeutics, Plc | $17.76 | 2021 | |
| Eisai INC. | $17.40 | 2021 | |
| Pulmonx Corporation | $17.30 | 2019 | |
| Advanced Respiratory, INC | $16.83 | 2020 | |
| Verona Pharma, INC. | $16.39 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $15.90 | 2025 | Zepbound |
| Allergan, INC. | $13.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bohner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.